Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Mar;9(2):101-8.
doi: 10.1007/s10006-005-0601-0.

[Chemodenervation with botulinumtoxin in masseteric hypertrophy]

[Article in German]
R A Mischkowski  1 , M Siessegger, F Lazar, J E Zöller
Affiliations

[Chemodenervation with botulinumtoxin in masseteric hypertrophy]

[Article in German]
R A Mischkowski et al. Mund Kiefer Gesichtschir. 2005 Mar.

Abstract

Background: Masseteric hypertrophy is a unilateral or bilateral enlargement of the masseteric muscle of various aetiologies. The therapeutic options range from solely conservative measures, especially in functionally induced abnormalities, up to surgical ablation of the muscle. The presented study evaluates the application of botulinum toxin serotype A for the treatment of masseteric hypertrophy.

Patients and methods: Between June 2000 and August 2004 seven patients with a unilateral and one patient with a bilateral manifestation of the condition were treated by an injection of botulinum toxin.

Results: A significant improvement of facial asymmetry caused by chemodenervation and following reduction of the hypertrophic muscle mass could be achieved in all cases. Complications during the injection, side effects, signs of intoxication, and therapy failure were not observed.

Conclusion: The results of this treatment series show in agreement with the reports in the literature that the application of botulinum toxin can be currently considered as the therapy of choice in masseteric hypertrophy.

PubMed Disclaimer

References

    1. J Neurol. 2002 Mar;249(3):345 - PubMed
    1. Int J Oral Maxillofac Surg. 2003 Jun;32(3):253-6 - PubMed
    1. Plast Reconstr Surg. 2001 Feb;107(2):327-32 - PubMed
    1. Dermatol Surg. 2003 May;29(5):477-83; discussion 483 - PubMed
    1. J Oral Maxillofac Surg. 1999 Aug;57(8):1017-9 - PubMed

Publication types

Substances

LinkOut - more resources